ADHD Drug's hidden effect on brain inflammation revealed

NCT ID NCT07041333

Completed Knowledge-focused Sponsor: Enes Faruk ALTUNKILIÇ Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether methylphenidate, a common ADHD medication, changes levels of brain inflammation markers in children aged 6 to 11. Researchers measured three inflammation-related substances in the blood of 42 children before and after 3 months of treatment. The goal was to understand how the drug might affect inflammation in the brain, not to test if the drug works for ADHD symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY (ADHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder Neuroinflammatory Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY (ADHD)

Contacts and locations

Locations

Bakırköy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospita

Istanbul, Bakırkoy, 34147, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.